The current mainstay of management of chronic beryllium disease involves cessation of beryllium exposure and use of systemic corticosteroids. However, there are no randomized controlled trials to assess the effect of these interventions on the natural history of this disease. Despite this limitation, it is prudent to remove patients with chronic beryllium disease from further exposure and consider treating progressive disease early with long-term corticosteroids. The effect of treatment should be monitored using pulmonary function tests and high-resolution computed tomography of the chest. However, once pulmonary fibrosis has developed, corticosteroid therapy cannot reverse the damage.

中文翻译：

---

目前治疗慢性铍病。

目前慢性铍病的主要治疗方法包括停止铍暴露和使用全身性皮质类固醇。然而，没有随机对照试验来评估这些干预措施对这种疾病的自然病程的影响。尽管有这种限制，但谨慎的做法是将慢性铍病患者从进一步暴露中排除，并考虑使用长期皮质类固醇及早治疗进展性疾病。应使用肺功能测试和胸部高分辨率计算机断层扫描来监测治疗效果。然而，一旦肺纤维化发生，皮质类固醇治疗就无法逆转这种损害。